Immunomodulatory Effects of IFNα on T and NK Cells in Chronic Myeloid Leukemia Patients in Deep Molecular Response Preparing for Treatment Discontinuation. This evidence concerns the gene IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive.